Palisade Bio
PALI
7 hedge funds and large institutions have $7.85M invested in Palisade Bio in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
309% more capital invested
Capital invested by funds: $1.92M → $7.85M (+$5.93M)
174% more call options, than puts
Call options by funds: $743K | Put options by funds: $271K
133% more funds holding
Funds holding: 3 → 7 (+4)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.29M |
| 2 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
+$763K |
| 3 |
BlackRock
New York
|
+$381K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$381K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$381K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$25K |
| 2 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$14K |
| 3 |
State Street
Boston,
Massachusetts
|
-$12K |
| 4 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$6K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1K | – | – | – |
|
|
NC
27
NewSquare Capital
Newtown Square,
Pennsylvania
| $1K | – | – | – |
|
|
SPIA
28
Steward Partners Investment Advisory
New York
| $1K | – | – | – |
|
|
CFA
29
CT Financial Advisors
Chadds Ford,
Pennsylvania
| $861 | – | – | – |
|
|
30
Bank of New York Mellon
New York
| – | -$25K | – | – |
|
|
31
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | -$4K | – | – |
|
|
FA
32
FCG Advisors
Chatham,
New Jersey
| – | -$6K | – | – |
|
|
FHC
33
First Heartland Consultants
Lake St. Louis,
Missouri
| – | -$3K | – | – |
|
34
Goldman Sachs
New York
| – | -$3K | – | – |
|
|
GC
35
Guggenheim Capital
Chicago,
Illinois
| – | -$14K | – | – |
|
36
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – | -$3K | – | – |
|
|
37
State Street
Boston,
Massachusetts
| – | -$12K | – | – |
|
PALI Hedge Fund Activity: Q1 2017 in Review
7 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2017, worth a combined $7.85M — up 309% from $1.92M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PALI positions and 0 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $2.29M. The largest seller was Bank of New York Mellon, cutting an estimated $25K.
- 7 institutional investors held Palisade Bio (PALI) as of Q1 2017, up from 3 in Q4 2016.
- Funds reported $7.85M of Palisade Bio stock for Q1 2017, up 309% quarter-over-quarter.
- 5 funds opened new Palisade Bio positions in Q1 2017 and 0 closed out, a net change of +5 holders.
- The largest Palisade Bio buyer in Q1 2017 was Sabby Management, an estimated $2.29M added.
- The largest Palisade Bio seller in Q1 2017 was Bank of New York Mellon, an estimated $25K sold.
Based on aggregated 13F filings for Q1 2017.